These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1320910)

  • 1. Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer.
    Herrstedt J; Clementsen P; Hansen OP
    Eur J Cancer; 1992; 28A(6-7):1070-3. PubMed ID: 1320910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.
    Niho S; Kubota K; Yoh K; Goto K; Ohmatsu H; Nihei K; Saijo N; Nishiwaki Y
    J Thorac Oncol; 2008 Jul; 3(7):723-7. PubMed ID: 18594317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
    Asamoto H; Kawahara M; Iwami F; Kuba M; Furuse K; Tamura T; Saijo N; Shimoyama M
    Jpn J Clin Oncol; 1998 Dec; 28(12):745-8. PubMed ID: 9879292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of myelosuppression on the response to chemotherapy in small cell bronchogenic carcinoma.
    Holoye PY; Kalbfleisch J
    Cancer; 1984 Aug; 54(3):411-5. PubMed ID: 6329504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
    J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
    Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
    Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: a phase I study.
    Klautke G; Fähndrich S; Semrau S; Büscher C; Virchow C; Fietkau R
    Lung Cancer; 2006 Aug; 53(2):183-8. PubMed ID: 16757061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    Pfeiffer P; Sørensen P; Rose C
    Eur J Cancer; 1995; 31A(1):64-9. PubMed ID: 7695981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of small cell lung cancer with ipsilateral pleural effusion].
    Oomori H; Matsui K; Nakagawa K; Masuda N; Itoh K; Kudoh S; Takifuji S; Kusunoki Y; Takada M; Negoro S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1085-90. PubMed ID: 1324375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of cepharanthin on leukopenia and thrombocytopenia induced by chemotherapy in lung cancer patients].
    Suzuki R; Hara M; Shindoh J; Matsumoto S; Noda Y; Gonda H; Tanaka H; Taki F; Takagi K
    Gan To Kagaku Ryoho; 1992 May; 19(5):647-52. PubMed ID: 1316101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study.
    D'Hondt V; Weynants P; Humblet Y; Guillaume T; Canon JL; Beauduin M; Duprez P; Longueville J; Müll R; Chatelain C
    J Clin Oncol; 1993 Nov; 11(11):2063-71. PubMed ID: 8229120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
    Kitamura K; Kubota K; Ando M; Takahashi S; Nishijima N; Sugano T; Toyokawa M; Miwa K; Kosaihira S; Noro R; Minegishi Y; Seike M; Yoshimura A; Gemma A
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):457-61. PubMed ID: 23178954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CVM versus ACE in the treatment of small cell lung cancer.
    Jones AL; Holborn J; Ashley S; Smith IE
    Oncology; 1993 Nov; 50 Suppl 2():10-5. PubMed ID: 8233295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
    Johnson DH; DeLeo MJ; Hande KR; Wolff SN; Hainsworth JD; Greco FA
    J Clin Oncol; 1987 May; 5(5):703-9. PubMed ID: 3033161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
    Ihde DC; Mulshine JL; Kramer BS; Steinberg SM; Linnoila RI; Gazdar AF; Edison M; Phelps RM; Lesar M; Phares JC
    J Clin Oncol; 1994 Oct; 12(10):2022-34. PubMed ID: 7931470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
    Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E
    Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
    Ueoka H; Ohnoshi T; Hiraki S; Kawahara S; Numata T; Nishii K; Yonei T; Yamashita H; Moritaka T; Kiura K
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2251-5. PubMed ID: 2544149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).
    Laack E; Thöm I; Krüll A; Engel-Riedel W; Müller T; Meissner C; Dürk H; Fischer J; Gütz S; Kortsik C; Elbers M; Schuch G; Andritzky B; Görn M; Burkholder I; Edler L; Hossfeld DK; Bokemeyer C
    Lung Cancer; 2007 Aug; 57(2):181-6. PubMed ID: 17442447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
    Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
    Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.